The Venture Codex Logo

The Venture Codex

GenHenn Capital

P.O. Box 692, Cranbury, NJ, 08512, United States

Overview

Single-family office specializing in private equity and venture capital.

Founded

2022

Deals · 12mo

1

Links

Website

Stage focus

Series A
Series B

Geographic focus

Switzerland
United States

Sector focus

—

Investment portfolio

9rounds
NAMEDATESIZE
Meduloc
Aug 2026Led
$4 MSeries B
DermaSensor
Oct 2025Participated
$16 MSeries B
PreciseDx
Jun 2025Participated
$11 MOther Equity
PreciseDx
Aug 2024Participated
$21 MSeries B
Prana Thoracic
Aug 2024Participated
$3 MSeries A
GeNeuro
Feb 2024Participated
$5 MOther Equity
MEND
Jun 2023Participated
$15 MSeries A
Diligent Pharma
May 2023Participated
$8 MSeries A
Xenocor
Apr 2023Led
$10 MSeries A
Meduloc
Aug 2026Led
$4 MSeries B
DermaSensor
Oct 2025Participated
$16 MSeries B
PreciseDx
Jun 2025Participated
$11 MOther Equity
PreciseDx
Aug 2024Participated
$21 MSeries B
Prana Thoracic
Aug 2024Participated
$3 MSeries A
GeNeuro
Feb 2024Participated
$5 MOther Equity
MEND
Jun 2023Participated
$15 MSeries A
Diligent Pharma
May 2023Participated
$8 MSeries A
Xenocor
Apr 2023Led
$10 MSeries A
9
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

GenHenn Capital: 9 funding rounds are recorded in the selected participation categories.All available history.
GenHenn Capital: 9 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A13
Series B12
Other Equity02

Monthly Deal Activity

GenHenn Capital: 9 deals are recorded across 43 months.All available history.
GenHenn Capital: 9 deals are recorded across 43 months. All available history
MonthDeals
Apr '231
May '231
Jun '231
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '241
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '242
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '251
Jul '250
Aug '250
Sep '250
Oct '251
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '261
Sep '260
Oct '260

Sector Breakdown

GenHenn Capital: Health & Life Sciences is the largest displayed sector by deal count (9 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

GenHenn Capital: Health & Life Sciences is the largest displayed sector by deal count (9 deals). All available history
SectorDeals
Health & Life Sciences9
Hardware & Robotics1
Manufacturing1
AI & Machine Learning1

Deal Size Distribution

GenHenn Capital: 9 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

GenHenn Capital: 9 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M2
$10M-$25M5
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

GenHenn Capital: United States has the largest recorded deal count among the displayed regions (8 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

GenHenn Capital: United States has the largest recorded deal count among the displayed regions (8 deals). All available history
RegionDeals
United States8
Europe1
GenHenn Capital: 20 co-investors are shown, with Eventide Asset Management sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

GenHenn Capital: 20 co-investors are shown, with Eventide Asset Management sharing 2 recorded deals. All available history
Co-investorShared deals
Eventide Asset Management2
Labcorp2
Quest Diagnostics2
Alumni Ventures1
Baranco Investments1
Barvest Ventures1
Ben Franklin Technology Partners of Southeastern Pennsylvania1
Broad Street Angels1
Cancer Prevention and Research Institute of Texas1
Colorcon Ventures1
cultivate(MD)1
FCA Venture Partners1
Houston Angel Network1
iSelect Fund1
Johnson & Johnson Innovation1
Keen Growth Capital1
Kern Venture Group1
Life Sciences Greenhouse Investments 1
Merck1
New World Angels1

Investment Strategy

GenHenn Capital: Led accounts for 22% and participating for 78% of round participation.All available history.
GenHenn Capital: Led accounts for 22% and participating for 78% of round participation. All available history
CategoryDeals (count)Share (%)
Led222%
Participating778%
GenHenn Capital: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
GenHenn Capital: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead2100%
Co-led00%

Team

Bill Hagaman